aescolab

Private

BerlinHealthcare & Life Scienceshttps://www.aescolab.de/en

Last Round

Seed

Jun 3, 2025

Company Overview

aescolab is a healthtech company that provides high-quality blood biomarker analyses and personalized lifestyle recommendations to help individuals and employees improve their energy and well-being.

Sector

Healthcare & Life Sciences

Verticals

Healthcare Analytics, D2C Brands, HR

Business Model

B2C

Customer Profile

Usage-Based SaaS

AI Layer

Application

Keywords

blood biomarker analysispersonalized healthpreventive healthhealth optimizationbiohackinghealthtechcorporate wellnessemployee health programsdigital health platformlongevitydata-driven healthabsenteeism reductionwellness techD2Cdirect-to-consumer health

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

aescolab Comps

Public and private peers based on sector, stage, and business model.

aescolab comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

aescolab Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Seed	Jun 3, 2025
VC Round	Apr 6, 2025
Seed	Nov 1, 2024

View all Funding Rounds

Key People

Founding team and executive leadership

Ruth Biallowons

Chief Medical Officer And Co-Founder

Founding Team

Tobias Moertel

COO Co-Founder

Founding Team

Stephan Alexander Dreier

Chief Executive Officer Co-Founder

Founding Team

Bruno Fischetti

Chief Technology Officer

Executive Team

View all key people

aescolab Investors

Notable investors and investment history

aescolab investors
Investor	Rounds
KRING	VC Round, Seed

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Feb 23, 2026
Grew 36% QoQ, from 14 to 19 employees.
Jan 23, 2026
Grew 36% QoQ, from 14 to 19 employees.

View all signals

aescolab Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

aescolab Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about aescolab's valuation, stock price, and market status.

Firmographic Details

HeadquartersBerlin

Employee Range15

Year Founded2024

Last FundingJun 3, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.